###begin article-title 0
Insulin Signaling Regulates Mitochondrial Function in Pancreatic beta-Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: SL OS EDA RK. Performed the experiments: SL TO AA JS CWL HB EDA. Analyzed the data: SL OS EDA RK. Wrote the paper: SL RK.
###end p 1
###begin p 2
Current address: Nagareyama General Hospital, Chiba, Japan
###end p 2
###begin p 3
###xml 318 319 315 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 454 455 442 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 735 736 720 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 570 578 <span type="species:ncbi:9606">patients</span>
Insulin/IGF-I signaling regulates the metabolism of most mammalian tissues including pancreatic islets. To dissect the mechanisms linking insulin signaling with mitochondrial function, we first identified a mitochondria-tethering complex in beta-cells that included glucokinase (GK), and the pro-apoptotic protein, BADS. Mitochondria isolated from beta-cells derived from beta-cell specific insulin receptor knockout (betaIRKO) mice exhibited reduced BADS, GK and protein kinase A in the complex, and attenuated function. Similar alterations were evident in islets from patients with type 2 diabetes. Decreased mitochondrial GK activity in betaIRKOs could be explained, in part, by reduced expression and altered phosphorylation of BADS. The elevated phosphorylation of p70S6K and JNK1 was likely due to compensatory increase in IGF-1 receptor expression. Re-expression of insulin receptors in betaIRKO cells partially restored the stoichiometry of the complex and mitochondrial function. These data indicate that insulin signaling regulates mitochondrial function and have implications for beta-cell dysfunction in type 2 diabetes.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kim1">[1]</xref>
###xml 457 460 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Datta1">[2]</xref>
###xml 749 752 746 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Assmann1">[3]</xref>
###xml 1002 1005 993 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Otani1">[4]</xref>
###xml 1007 1010 998 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni1">[5]</xref>
###xml 1012 1015 1003 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni2">[6]</xref>
###xml 1017 1020 1008 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Assmann2">[7]</xref>
###xml 1283 1286 1268 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Okada1">[8]</xref>
###xml 566 571 <span type="species:ncbi:10090">mouse</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
Insulin and insulin like growth factor I (IGF-I) play critical roles in triggering pleiotropic actions including metabolism, proliferation and survival in most mammalian cells including the pancreatic islets [1]. The two hormones bind to their cognate receptors and activate Akt/protein kinase B via the phosphatidylinositol 3-kinase (PI3-K)-generated polyphospho-phosphatidylinositol pathway to phosphorylate the protein BAD in the regulation of apoptosis [2]. Indeed, we and several other laboratories have used cell line, primary islet and genetically engineered mouse models to demonstrate that insulin/IGF-I signaling plays a critical role in the regulation of hormone secretion, proliferation and survival of pancreatic beta-cells (see review [3]). Among the various models, it is notable that mice with beta-cell specific knockout of insulin receptors (betaIRKO) and/or IGF-1 receptors demonstrate reduced expression of the glucokinase (GK) gene and blunted glucose-stimulated insulin secretion [4], [5], [6], [7]. betaIRKO mice also display an age-dependent decrease in islet mass, poor compensatory islet response to high fat-diet induced islet growth and increased susceptibility to diabetes, suggesting a role for insulin signaling in the regulation of beta-cell survival [8].
###end p 5
###begin p 6
###xml 234 237 225 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Anello1">[9]</xref>
###xml 291 295 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Matschinsky1">[10]</xref>
###xml 297 301 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Matschinsky2">[11]</xref>
###xml 329 333 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Wiederkehr1">[12]</xref>
###xml 335 339 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Veluthakal1">[13]</xref>
###xml 419 423 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial1">[14]</xref>
###xml 592 595 580 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Anello1">[9]</xref>
###xml 445 453 <span type="species:ncbi:9606">patients</span>
While the precise defect in beta-cell growth and/or function that triggers overt diabetes is not fully understood, mitochondrial dysfunction in beta-cells has been implicated as one factor that impairs beta-cell survival and function [9]. Mitochondria play a major role in insulin secretion [10], [11] and in beta-cell apoptosis [12], [13] triggered by diverse internal or external cues ultimately promoting cell death [14]. Indeed, islets from patients with type 2 diabetes exhibit low ATP content and a blunted glucose-stimulated insulin secretion (GSIS) and increased mitochondrial volume [9], together implicating a role for mitochondria in the pathogenesis of beta-cell dysfunction.
###end p 6
###begin p 7
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kurmasheva1">[15]</xref>
###xml 366 370 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial2">[16]</xref>
###xml 522 526 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Lee1">[17]</xref>
###xml 528 532 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kim2">[18]</xref>
###xml 723 726 714 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni1">[5]</xref>
###xml 728 732 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni3">[19]</xref>
Growth factor-mediated pathways have been reported to modulate mitochondrial function and regulate the activity of the pro-apoptotic protein, BAD [15]. Interestingly, studies in hepatocytes and beta-cells have shown the presence of a BAD/glucokinase complex at the mitochondria suggesting a point of intersection for processes that regulate glycolysis and apoptosis [16]. Further, hyperglycemia has been reported to modulate the levels of GK and alter its interactions with mitochondria leading to apoptosis of beta-cells [17], [18]. Considering the critical role of glucokinase in cellular metabolism and survival, and our previous observations of reduced expression of GK in beta-cells lacking insulin or IGF-1 receptors [5], [19], we undertook the current study to explore whether absence of insulin signaling in beta-cells impacts mitochondrial function.
###end p 7
###begin p 8
###xml 214 215 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 300 301 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
In this study, we report the presence of a BAD/GK complex at the mitochondria in mouse and human beta-cells. Furthermore, we provide evidence that lack of insulin receptors in beta-cells impacts localization of BADS, alters the stoichiometry of the BAD/GK complex and modulates phosphorylation of BADS that together contribute to defects in mitochondrial function.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Identification of BAD/glucokinase complex in beta-cell mitochondria
###end title 10
###begin p 11
###xml 343 347 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial2">[16]</xref>
###xml 525 526 516 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 528 537 519 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g001">Fig. 1A&#8211;C</xref>
###xml 924 931 912 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g001">Fig. 1D</xref>
###xml 1095 1102 1083 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g001">Fig. 1D</xref>
###xml 1214 1221 1202 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g001">Fig. 1D</xref>
###xml 1247 1251 1235 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Lee1">[17]</xref>
###xml 1256 1257 1244 1245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1300 1301 1288 1289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1445 1452 1433 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g001">Fig. 1D</xref>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 623 628 <span type="species:ncbi:10090">mouse</span>
###xml 633 638 <span type="species:ncbi:9606">human</span>
To explore the presence of a putative BAD/GK complex in beta cells, we isolated mitochondria from beta-cell lines, or islets derived from control or betaIRKO mice and from diabetic and non-diabetic human subjects. Mitochondria were subjected to microcystin pull down assays. Similar to descriptions of the mitochondrial complex in hepatocytes [16], we detected five proteins: WAVE1 (a protein kinase A scaffold protein), glucokinase (GK), protein kinase A (PKA), protein phosphatase 1 (PP1), and the pro-apoptotic protein BADS (Fig. 1A-C). All components of the BAD/GK complex were identified in cultured beta-cells and in mouse and human islets, indicating that this complex is conserved across species. Evaluation of the distribution of each component in cytosolic and mitochondrial fractions revealed that WAVE1 exists largely in the cytosol and mitochondrial WAVE1 comprises a small proportion of cellular WAVE protein (Fig. 1D). Interestingly, we observed robust expression of glucokinase in mitochondrial fractions when equal amounts of protein from mitochondria and cytososl were loaded (Fig. 1D). However, it is likely that the amount of GK that resides in the cytosol is greater than at the mitochondria (Fig. 1D). Among the BAD isoforms [17], BADL largely localized to the cytosol while BADS was identified in both cytosolic and mitochondrial fractions. On the other hand, PKA and PP1 were detectable in both cytosol and mitochondria (Fig. 1D).
###end p 11
###begin title 12
Presence of BAD/GK complex in mitochondria.
###end title 12
###begin p 13
###xml 651 652 636 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
Upper panels: Western blotting of five components in the BAD/GK complex with the indicated antibodies. Lower panels: Mean data after quantitation. Each component was normalized to PP1 and control samples were set to an arbitrary level of 1. A, control (Con) and betaIRKO beta-cell lines. B, control and betaIRKO islet cells. C, islet cells from controls or patients with type 2 diabetes. Representative of 3-5 independent experiments. * p<0.05; ** p<0.001 versus Control. Open bar: controls; Shaded bar: betaIRKO or type 2 diabetes beta-cells. WAVE1, A protein kinase A scaffold; GK, glucokinase; PP1, protein phosphotase 1; PKA, protein kinase A; BADS, BCL2-antagonist of cell death. D, Western blotting of five components in BAD/GK complex in cytosolic and mitochondrial compartments fractionated from control (Con) or betaIRKO (KO) beta-cell lines. Equal amount of proteins was loaded in each lane. Using total amount of protein loaded for the cytosol and mitochondria approximately20% of total cellular GK is associated with mitochondria. L and S denote the large and small isoforms of BAD respectively.
###end p 13
###begin p 14
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 299 308 293 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g001">Fig. 1A&#8211;C</xref>
###xml 313 320 307 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s004">Fig. S4</xref>
###xml 431 438 419 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g001">Fig. 1A</xref>
###xml 691 692 673 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 252 258 <span type="species:ncbi:9606">humans</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 660 666 <span type="species:ncbi:9606">humans</span>
Assessment of the effects of absence of insulin receptors or of insulin resistance on the complex, revealed a significant reduction in BADS in mitochondrial samples from beta-cell lines or islets isolated from betaIRKO mice and in islets isolated from humans with diabetes (75% of control, p<0.05) (Fig. 1A-C and Fig. S4). In mitochondria from beta-cell lines isolated from betaIRKO mice, PKA was reduced (12% of control, p<0.05) (Fig. 1A), and we also observed a trend towards a decrease in GK protein (29% of control, p = 0.08) in the mutants. Together, these data indicate that absence of insulin signaling in beta-cells (betaIRKO) or the diabetic state in humans is linked to reduced BADS in the mitochondrial complex.
###end p 14
###begin title 15
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
BADS phosphorylation, p70S6K and JNK signaling
###end title 15
###begin p 16
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Datta2">[20]</xref>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Datta2">[20]</xref>
###xml 354 355 354 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 547 554 541 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s001">Fig. S1</xref>
BADS, a pro-apoptotic protein belonging to the Bcl-2 family, can be phosphorylated in response to growth factors at three sites, Ser-112, Ser-136 or Ser-155 [20]. Kinases implicated in activating serine phosphorylation on BAD, include Akt/protein kinase B, p70S6K, PKA, Rsk, and PAK1 [20]. To investigate the role of insulin versus IGF-I in mediating BADS phosphorylation in beta-cells, we stimulated beta-cells with either hormone and examined mitochondrial or cytosolic fractions. For all experiments, the purity of the fractions was confirmed (Fig. S1).
###end p 16
###begin title 17
###xml 43 44 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 82 83 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
betaIRKO mitochondria exhibit decreased BADS but increased Ser-112 and Ser-136 BADS
###end title 17
###begin p 18
###xml 27 28 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 131 138 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2A</xref>
###xml 163 164 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 317 318 311 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 345 352 336 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2B</xref>
###xml 423 427 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Fernandez1">[21]</xref>
###xml 432 439 423 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2D</xref>
Consistent with reduced BADS protein in the BAD/GK complex, BADS content was reduced in mitochondria isolated from betaIRKO cells (Fig. 2A). Phosphorylation of BADS at Ser-112 was increased in betaIRKO mitochondria but was virtually undetectable in control cells. Furthermore insulin stimulation increased Ser-112 BADS in betaIRKO mitochondria (Fig. 2B), which likely reflects insulin signaling via intact IGF-1 receptors ([21] and Fig. 2D).
###end p 18
###begin title 19
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
Altered expression of BADS and phospho-BADS in mitochondria and cytosol.
###end title 19
###begin p 20
###xml 237 450 234 447 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Figures A though G, the upper panels show representative Western blots and lower panels show mean values after quantitation of data. In H a representative Western blot is shown. Figures A, B, C and D relate to </bold>
###xml 588 589 585 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 998 1001 983 984 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#177;</bold>
###xml 1079 1081 1059 1061 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S,</sub>
###xml 1149 1150 1129 1130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
Control or betaIRKO cells were treated with 100 nM of either insulin or IGF-I for 15 min and fractionated mitochondria and cytosol were examined. Protein levels were assessed by densitometry. Controls were set to an arbitrary evel of 1. In Figures A though G, the upper panels show representative Western blots and lower panels show mean values after quantitation of data. In H a representative Western blot is shown. Figures A, B, C and D relate to alterations in isolated mitochondrial fractions and Figures E, F, and G relate to alterations in cytosolic fractions. A, Reduced total BADS, * p<0.05 betaIRKO vs control cells. B, Mitochondrial BADs phosphorylation at Ser-112, * p</=0.05, basal vs insulin stimulation, n = 3. ND, non-detectable. C, Mitochondrial BADs phosphorylation at Ser-136, * p</=0.05, basal vs insulin stimulation, n = 3. D, Mitochondrial BADs phosphorylation at Ser-112 and Ser-136 under basal or IGF-I stimulated conditions, * p</=0.05 vs. Control basal; # p<0.05, betaIRKO+/-IGF-I; n = 3. Open bar: controls; Shaded bar: betaIRKO. E, Total cytosolic BADS, * p<0.05. F and G, Ser-112 phosphorylation pattern of cytosolic BADS upon insulin (F) or IGF-I (G) treatments. * p<0.05 control basal vs betaIRKO basal; # p<0.05, control+/-insulin/IGF-I. H, Total BAD in whole cell lysates. Open bar: controls; Shaded bar: betaIRKO.
###end p 20
###begin p 21
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 80 81 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 215 222 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2C</xref>
###xml 309 317 306 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s002">Fig. S2A</xref>
###xml 353 354 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 434 435 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 495 496 489 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 791 792 779 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 817 821 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Bonni1">[22]</xref>
###xml 970 971 955 956 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1042 1049 1024 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2D</xref>
Relative to total levels of BADS, basal levels of Ser-136 phosphorylation of BADS were also increased in betaIRKO mitochondria versus controls, and phosphorylation tended to increase further with insulin treatment (Fig. 2C). Compared to changes in Ser-112 phosphorylation, these changes were not as dramatic (Fig. S2A, B). Given the low abundance of BADS in the betaIRKO mitochondria we conclude that the majority of the remaining BADS was in the phosphorylated state. The phosphorylation of BADS is unlikely to involve Akt since its activation is extremely low in betaIRKO cells (see below). On the contrary, phosphorylation of BAD is likely due to enhanced IGF-I signaling in betaIRKO cells (see below) that potentially activates RSK1, which in turn, has been reported to phosphorylate BADS at both Ser-112 and 136 [22]. In support of this hypothesis, and consistent with enhanced IGF-I signaling in betaIRKO cells, we observed increased Ser-112 phosphorylation of BADS in betaIRKO but not in control cells following incubation with IGF-I (Fig. 2D).
###end p 21
###begin title 22
###xml 40 41 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 67 68 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
betaIRKO cytosol expresses increased BADS and decreased Ser-112 BADS
###end title 22
###begin p 23
###xml 158 159 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 257 258 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 355 366 352 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2E,F,G</xref>
###xml 435 436 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 567 568 561 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 665 666 659 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 703 710 694 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2H</xref>
###xml 715 723 706 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s002">Fig. S2A</xref>
###xml 739 740 730 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1014 1015 999 1000 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1066 1067 1051 1052 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1119 1127 1104 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s002">Fig. S2A</xref>
###xml 1129 1133 1114 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Masters1">[23]</xref>
To evaluate relative changes in cytosol versus mitochondria, we next examined signaling events in cytosolic fractions. In betaIRKO cytosol, the pattern of BADS expression and phosphorylation were different than that observed in mitochondria. Thus, total BADS showed a trend towards an increase but Ser-112 phosphorylation was reduced in basal conditions (Fig. 2E,F,G). The mitochondrial and cytosolic data collectively suggest that BADS is redistributed away from the mitochondria in the cytosol in betaIRKO cells without a change in the total cellular content of BADS. This was confirmed following analysis of whole cell lysates showing no differences in total BADS between betaIRKO and control cells (Fig. 2H and Fig. S2A). Cytosolic BADS protein content tended to increase in insulin stimulated control cells, but did not change in betaIRKO cells. One possible explanation for these observations is that increased Akt activation, in control relative to betaIRKO cells results in increased phosphorylation of BADS at Ser-136 leading to sequestration of Ser-136 BADS with 14-3-3 proteins in the cytoplasm of controls (Fig. S2A) [23]. Therefore, relative to betaIRKO cells, there is more cytosolic Ser-136 BADs in control cells, which is consistent with increased Akt-mediated phosphorylation and cytosolic sequestration in control cells.
###end p 23
###begin p 24
###xml 125 126 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 179 188 179 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2F,G</xref>
###xml 434 435 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 457 466 454 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2F,G</xref>
###xml 522 523 519 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 571 578 568 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2B</xref>
###xml 583 591 580 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s002">Fig. S2A</xref>
###xml 632 633 629 630 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 782 789 773 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2D</xref>
###xml 907 916 895 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2F,G</xref>
In the cytosolic fractions extracted from control cells, we observed a significant decrease in Ser-112 phosphorylation of BADS in response to either insulin or IGF-I stimulation (Fig. 2F,G). The mechanism for this attenuation is uncertain, but these observations raise the possibility that Ser-112 phosphorylation might be negatively regulated by insulin or IGF-I mediated activation of Akt. betaIRKO cytosol contains less Ser-112 BADS compared to control (Fig. 2F,G), which may suggest that phosphorylation of Ser-112 BADS, may preferentially occur at the mitochondria (Fig. 2B and Fig. S2A). Indeed, Ser-112 phosphorylation of BADS in betaIRKO cytosol did not increase following insulin treatment. In contrast, IGF-I treatment increased Ser-112 phosphorylation in betaIRKO cells (Fig. 2D) (p<0.05), suggesting that the IGF-I signaling module that activates BAD, might be hyperactivated in betaIRKO cells (Fig. 2F,G).
###end p 24
###begin title 25
betaIRKO cells show increased mitochondrial P70S6K and JNK1 activation
###end title 25
###begin p 26
###xml 225 229 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Harada1">[24]</xref>
###xml 429 436 423 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g003">Fig. 3A</xref>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 212 215 <span type="species:ncbi:10116">Rat</span>
We next explored potential mechanisms that could account for the preferential increase in phosphorylation of BAD in mitochondria of betaIRKO mice. Consistent with the existence of mitochondria-tethered p70S6K in Rat-1a cells [24], we also detected this kinase in mitochondria in beta-cells. Indeed, similar to other insulin sensitive cells, insulin stimulation of control cells increased phosphorylation of mitochondrial p70S6K (Fig. 3A).
###end p 26
###begin title 27
Altered phospho-p70S6K and phospho-JNK1 activation in mitochondria.
###end title 27
###begin p 28
Control or betaIRKO cells were treated with 100 nM of either insulin or IGF-I for 15 min and fractionated cytosol and mitochondria were used for analyses. Controls were set to an arbitrary level of 1. In each Figure, the upper panel shows the representative Western blot and lower panel shows the mean value after quantitation of data. A, Responses in mitochondrial p70S6K to insulin treatment. * p<0.05; # p</=0.05. B, Responses in cytosolic p70S6K to insulin treatment. * p = 0.06; # p = 0.078; C and D, Responses in mitochondrial and cytosolic p70S6K to IGF-I treatment in control and betaIRKO cells. * p<0.05; # p<0.05. E and F, Responses in mitochondrial and cytosolic JNK1 to IGF-I treatment in control and betaIRKO cells. # p<0.05. Open bar: controls; Shaded bar: betaIRKO.
###end p 28
###begin p 29
###xml 186 196 183 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g003">Fig. 3A, B</xref>
###xml 391 395 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Dickson1">[25]</xref>
###xml 509 510 506 507 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 536 540 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Harada1">[24]</xref>
###xml 709 716 700 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g003">Fig. 3C</xref>
###xml 853 860 841 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g003">Fig. 3D</xref>
betaIRKO mitochondria exhibited higher basal activation of Thr-389 p70S6K in the mitochondrial and cytosolic fractions, which did not increase any further following insulin stimulation (Fig. 3A, B). It is possible that this reflects the consequence of increased basal IGF-I signaling, particularly at the level of the mitochondria, acting via Akt-independent signaling pathways such as MAPK [25], which we believe provides a potential explanation for the elevated phosphorylation of Ser-112 and Ser-136 of BADS in betaIRKO mitochondria [24]. Indeed, in isolated mitochondria, addition of IGF-I significantly increased Thr-389 phosphorylation of p70S6K in the betaIRKOs but had minimal effect in the controls (Fig. 3C). In contrast, IGF-I did not further increase cytosolic Thr-389 phosphorylation of p70S6K beyond the elevated basal levels in betaIRKO (Fig. 3D).
###end p 29
###begin p 30
###xml 345 352 339 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g003">Fig. 3E</xref>
###xml 463 467 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Wiltshire1">[26]</xref>
###xml 697 706 688 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g003">Fig. 3E,F</xref>
###xml 831 840 822 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g003">Fig. 3E,F</xref>
###xml 970 974 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Lin1">[27]</xref>
###xml 1113 1122 1098 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g003">Fig. 3E,F</xref>
The JNK (c-Jun N-terminal kinase) pathway is activated by diverse stressors and can influence multiple cellular processes. Because mitochondrial dysfunction could activate stress signaling in beta-cells, we investigated JNK activity in mitochondria. JNK1 phosphorylation and total JNK1 protein was increased in mitochondria from betaIRKO cells (Fig. 3E), which is consistent with the report that JNK co-localizes with mitochondria through its interacting protein [26]. The trend towards increased basal JNK1 phosphorylation levels in mitochondria, but not in cytosolic fractions, suggests that JNK1 activation might be linked to the stress induced by dysfunctional mitochondria in betaIRKO cells (Fig. 3E,F). In control cells, IGF-I but not insulin, triggered phosphorylation of JNK1 in both mitochondrial and cytosolic fractions (Fig. 3E,F). Thus, the JNK/MAPK pathway is more responsive to IGF-I than to insulin in beta-cells as has been suggested in other cell types [27]. The lack of a similar effect of IGF-I in betaIRKO cells could be due to high basal activation of JNK1 that precludes further activation (Fig. 3E,F).
###end p 30
###begin p 31
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial2">[16]</xref>
Given the role of the BAD/GK complex in the regulation of glycolysis and apoptosis [16], and our observations of changes in the BAD/GK complex in betaIRKO mitochondria, we reasoned that these changes could be associated with impaired mitochondrial function in betaIRKO cells.
###end p 31
###begin title 32
Altered mitochondrial function in betaIRKO beta-cells and islets
###end title 32
###begin title 33
Blunted glucose-stimulated mitochondrial membrane potential response in betaIRKO beta-cells and islets
###end title 33
###begin p 34
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Heart1">[28]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Wikstrom1">[29]</xref>
###xml 273 280 273 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 557 566 545 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g004">Fig. 4A,B</xref>
###xml 626 634 611 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s003">Fig. S3A</xref>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
Mitochondria respond to glucose stimulation in a dose-dependent manner by altering their membrane potential and mitochondrial metabolism, which plays a determinant role in glucose-stimulated insulin secretion [28], [29]. To assess the membrane potential response in islets ex vivo, we performed experiments in dispersed islet beta-cells derived from control or betaIRKO mice using the mitochondrial dye (TMRE). beta-cells isolated from betaIRKO islets exhibited significantly reduced membrane potential response to glucose stimulation compared to controls (Fig. 4A,B) and similar results were observed in betaIRKO cell lines (Fig. S3A).
###end p 34
###begin title 35
Altered mitochondrial function in betaIRKO beta-cells.
###end title 35
###begin p 36
###xml 1156 1163 1123 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 1058 1062 <span type="species:ncbi:10090">mice</span>
###xml 1296 1300 <span type="species:ncbi:10090">mice</span>
###xml 1394 1398 <span type="species:ncbi:10090">mice</span>
A-B, Reduced mitochondrial membrane potential response to glucose stimulation in betaIRKO beta-cells. A, dispersed islet beta-cells from control or betaIRKO mice were stained by TMRE and analyzed by confocal microscopy. B, Fluorescence intensity in images was quantitated by NIH ImageJ. n = 3-5; # p<0.05, 5.5 mM vs 18 mM glucose. Open bar: controls; shaded bar: betaIRKO beta-cells. C-D, Reduced mitochondrial glucokinase activity in betaIRKO beta-cells. Glucokinase activity in freshly purified mitochondria from either control or betaIRKO cells is plotted as absorbance of glucose-6-phosphate dehydrogenase-driven increase in NADPH fluorescence (C). The activity is illustrated by the rates determined by measuring optical density changes over linear periods, between 5 and 20 minutes (D). Mean of three independent experiments is shown. The activities of controls were set to an arbitrary level of 1. * p<0.05. E-G, Altered mitochondrial number and size. Quantitative analyses of mitochondrial ultrastructrue in islet beta-cells from control or betaIRKO mice. Mitochondrial number (E), size (F), and volume density (G) were quantitated as described in Methods, * p<0.05, n = 5. H, Representative transmission electron microscopy (TEM) micrographs of islet beta-cells from control or betaIRKO mice. Arrowheads point mitochondria showing increased size in betaIRKOs. n = 28-30 cells from 3-5 mice. Magnification bar: 2 microM
###end p 36
###begin title 37
Decreased mitochondrial GK activity in betaIRKO beta-cells
###end title 37
###begin p 38
###xml 603 612 600 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g004">Fig. 4C,D</xref>
###xml 803 804 800 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 944 948 938 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial2">[16]</xref>
Increased mitochondrial membrane potential results from increased glycolysis and oxidative phosphorylation. We hypothesized that altered mitochondrial glucokinase activity contributes to the poor membrane potential response to glucose stimulation. We therefore measured glucokinase activity in mitochondria using the G6PDH-coupled enzyme assay. Freshly purified mitochondria from control cells showed a time-dependent increase in NADPH generation and glucokinase enzyme activity in response to glucose stimulation while there was significantly less NADPH generation in mitochondria from betaIRKO cells (Fig. 4C,D). NADPH generation was not observed following treatment with the non-metabolized analogue, 2-deoxy glucose, confirming specificity of the assay (data not shown). Thus, decreased level of BADS in the BAD/GK complex potentially leads to reduced mitochondrial GK activity in betaIRKO cells, consistent with the reports in hepatocytes [16].
###end p 38
###begin title 39
Decreased mitochondrial number and increased mitochondrial size in betaIRKO beta-cells
###end title 39
###begin p 40
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Gollapudi1">[30]</xref>
###xml 198 205 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g004">Fig. 4H</xref>
###xml 261 274 258 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g004">Fig. 4F and H</xref>
###xml 321 328 318 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g004">Fig. 4E</xref>
###xml 415 422 412 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g004">Fig. 4G</xref>
###xml 543 551 537 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s003">Fig. S3B</xref>
A potential cause of the decreased mitochondrial membrane potential response to glucose is altered mitochondrial mass [30]. Electron microscopy revealed that mitochondria in betaIRKOs were rounded (Fig. 4H, arrows) and larger than those in control islet cells (Fig. 4F and H), but the number of mitochondria was reduced (Fig. 4E). The mitochondrial volume densities, however, were not different between the groups (Fig. 4G). Mitotracker staining of betaIRKO cell lines revealed fluorescence consistent with no reduction in mitochondrial mass (Fig. S3B).
###end p 40
###begin title 41
Increased mitochondrial oxygen consumption but decreased cellular ATP content in betaIRKO beta-cells
###end title 41
###begin p 42
###xml 323 333 317 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g005">Fig. 5A, B</xref>
###xml 518 525 506 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g005">Fig. 5C</xref>
###xml 762 769 744 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g005">Fig. 5E</xref>
###xml 910 914 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Zhang1">[31]</xref>
###xml 1089 1096 1064 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g005">Fig. 5D</xref>
###xml 1302 1306 1260 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Oberkofler1">[32]</xref>
###xml 1308 1312 1266 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Oberkofler2">[33]</xref>
To further explore mechanisms that contribute to the lower mitochondrial membrane potential in the betaIRKOs, we measured oxygen consumption responses to treatment with glucose or DNP (2,4-dinitrophenol). Surprisingly, both control and betaIRKO cells responded with a similar rise in oxygen consumption to either stimulus (Fig. 5A, B). Despite similar increases in oxygen consumption in glucose-stimulated control and betaIRKO cells, there was a dramatic reduction in ATP content in glucose-stimulated betaIRKO cells (Fig. 5C). The increase in oxygen consumption, accompanied by reduced ATP generation, and a blunted increase in membrane potential suggests that betaIRKO mitochondria are significantly uncoupled. UCP2 expression was increased in betaIRKO cells (Fig. 5E) and could represent one mechanism for mitochondrial uncoupling in these cells, similar to that observed in other models of type 2 diabetes [31]. Interestingly, expression levels of PGC-1alpha in the betaIRKO cells were markedly increased, which likely represents a compensatory response to dysfunctional mitochondria (Fig. 5D). Recent studies have shown that PGC-1alpha and PGC-1beta are transcriptional regulators of UCP2, and that increased PGC-1alpha/beta - mediated upregulation of UCP2 may contribute to beta cell dysfunction [32], [33].
###end p 42
###begin title 43
Re-expression of insulin receptors improved altered mitochondrial function in betaIRKO beta-cells.
###end title 43
###begin p 44
A, Basal and 25 mM glucose stimulated oxygen consumption rates (OCR) in control, betaIRKO or betaIRKO cells re-expressing insulin receptors (betaIRKO+hIRB) cells, * p<0.05, n = 6. B, OCR response to 60 microM DNP (2,4-Dinitrophenol) in control, betaIRKO or betaIRKO+hIRB cells. OCRs were normalized by cell numbers in all assays, * p<0.05, n = 22. C, Re-expression of insulin receptors recovered the reduction of ATP production in betaIRKO cells in response to 25 mM glucose stimulation. After starvation, control, betaIRKO or betaIRKO+hIRB cells were treated with 2 mM and 25 mM glucose in KRB buffer for 30 min, ATP was extracted and measured, ** p<0.001, n = 3. D and E, Re-expression of insulin receptors reduced the PGC1alpha and UCP2 expression to control levels. Expression levels of PGC1alpha (D) and UCP2 (E) were assessed in control, betaIRKO or betaIRKO+hIRB cells using real-time PCR. All cells grown in normal culture conditions; mRNA was extracted and cDNA was synthesized for real-time PCR, * p<0.05, n = 3.
###end p 44
###begin title 45
Rescue of phenotype by re-expression of insulin receptors in betaIRKOs
###end title 45
###begin p 46
###xml 382 389 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g006">Fig. 6A</xref>
###xml 491 500 464 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g006">Fig. 6A,B</xref>
###xml 582 583 555 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 695 702 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g006">Fig. 6C</xref>
###xml 842 849 812 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g006">Fig. 6D</xref>
###xml 127 132 <span type="species:ncbi:9606">human</span>
To confirm that the defects in mitochondria in betaIRKO beta-cells are due to disrupted insulin signaling, we re-expressed the human insulin receptor-B isoform in betaIRKO beta-cells and revaluated the mitochondrial BAD/GK complex and mitochondrial function. In betaIRKO cells re-expressing insulin receptors, Akt phosphorylation was restored to approximately70% of control levels (Fig. 6A) and the enhancedexpression of IGF-1 receptors and phospho-p70S6K were normalized to control levels (Fig. 6A,B). In microcystin pull-down assays, we observed a near-complete restoration of BADS in the BAD/GK complex, while PKA was significantly higher in the re-expressors compared to betaIRKO fractions (Fig. 6C). Mitochondrial Thr-389 p70S6K and Ser-112 BAD phosphorylation were normalized in the absence of equivalent changes in phosphorylated JNK (Fig. 6D). However, the level of expression of GK in the complex was not completely restored suggesting that re-establishing insulin/Akt signaling only partially improves the stoichiometry of the BAD/GK complex in betaIRKO beta-cells.
###end p 46
###begin title 47
Normalization of signaling complexes after re-expression of insulin receptor B isoforms in betaIRKO beta-cells.
###end title 47
###begin p 48
###xml 1090 1091 1060 1061 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
A, Upper panel, Protein profile after expression of insulin receptors in betaIRKO cells was immunoblotted by antibodies as indicated. p-Akt of controls were set to an arbitrary level of 1, * p<0.05, n = 3. Lower panel shows quantitation of p-Akt to total Akt. B, Upper panel, P70S6K and phosphor-P70S6K were assessed in cytosolic fractions from control, betaIRKO or betaIRKO cells re-expressing insulin receptors (betaIRKO+hIRB), p-P70S6K of controls were set to an arbitrary level of 1, * p<0.05, n = 3. Lower panel shows quantitation of p-P70S6K to total p70S6K. C, Upper panel, microcystin pull down assays to demonstrate the five protein components of BAD/GK complex in mitochondria isolated from control, betaIRKO or betaIRKO cells re-expressing insulin receptors (betaIRKO+hIRB), * p<0.05. Lower panel, each component was normalized to PP1 which was set to an arbitrary level of 1 for each cell type. D, Mitochondrial fractions isolated from control, betaIRKO or betaIRKO cells re-expressing insulin receptors (betaIRKO+hIRB) were used to evaluate phosphorylation of JNK1, p70S6K, BADS. Arrow indicates total JNK1.
###end p 48
###begin p 49
###xml 193 202 190 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g005">Fig. 5A,B</xref>
###xml 301 308 298 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g005">Fig. 5C</xref>
###xml 313 321 310 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s003">Fig. S3A</xref>
###xml 401 410 394 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g005">Fig. 5D,E</xref>
In keeping with normalization of signaling complexes, re-expression of insulin receptors in betaIRKOs increased oxygen consumption rates even further following stimulation with glucose or DNP (Fig. 5A,B). ATP levels and mitochondrial membrane potential showed an increase in glucose-stimulated cells (Fig. 5C and Fig. S3A) and expression levels of PGC-1alpha and UCP2 were restored to control levels (Fig. 5D,E). Thus re-expression of insulin receptors restored mitochondrial energetics in betaIRKO cells in part by increasing mitochondrial coupling.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
In this study we examined the significance of insulin signaling on mitochondrial function in pancreatic beta-cells. We report that disruption of insulin signaling in beta-cells alters the stoichiometry of a mitochondrial BAD/GK complex, reduces GK activity and promotes mitochondrial dysfunction. Re-expression of the insulin receptor in beta-cells that lack insulin receptors largely restores the complex and improves mitochondrial function, highlighting a significant role for insulin signaling in the maintenance of the BAD/GK complex and in the regulation of mitochondrial function.
###end p 51
###begin p 52
###xml 284 288 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial2">[16]</xref>
###xml 468 472 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Smith1">[34]</xref>
###xml 725 728 710 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Otani1">[4]</xref>
###xml 730 733 715 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni2">[6]</xref>
###xml 806 807 791 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 986 990 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial2">[16]</xref>
###xml 992 996 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial3">[35]</xref>
###xml 1181 1182 1160 1161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1354 1357 1333 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Anello1">[9]</xref>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 1051 1057 <span type="species:ncbi:9606">humans</span>
###xml 1139 1143 <span type="species:ncbi:10090">mice</span>
###xml 1324 1332 <span type="species:ncbi:9606">patients</span>
The identification of a BAD/GK complex in both mouse and human beta-cells in this study indicates conservation across species and supports the concept of a potential functional link between apoptosis and glycolysis at the mitochondria, which is similar to observations in hepatocytes [16]. Indeed, the WAVE protein in the complex has been suggested to anchor GK and BAD to the mitochondria to efficiently co-ordinate spatial and temporal aspects of glucose metabolism [34]. The alterations in the expression of different components in the complex in mitochondria from beta-cells from betaIRKO provide potential insights into the altered function of beta-cells and may explain some of the phenotypes observed in betaIRKO mice [4], [6]. Similar to effects observed in BAD-deficient hepatocytes, decreased BADS protein in the betaIRKO cells likely contributes to mitochondrial dysfunction and beta-cell dysfunction, which may contribute to the glucose intolerance in both of these mutants [16], [35]. The BAD/GK complex was also disrupted in islets from humans with type 2 diabetes and showed an interesting similarity with islets from bIRKO mice. Thus it is possible that reduced BADS in the mitochondria may be linked to the blunted glucose response and altered mitochondrial ultra structure observed in islets isolated from patients with type 2 diabetes [9].
###end p 52
###begin p 53
###xml 167 171 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Boudina1">[36]</xref>
###xml 878 882 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Oberkofler1">[32]</xref>
###xml 884 888 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Oberkofler2">[33]</xref>
###xml 1052 1056 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Zhang1">[31]</xref>
###xml 1058 1062 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Pi1">[37]</xref>
###xml 1426 1430 1404 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Boudina1">[36]</xref>
###xml 1685 1693 1657 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s003">Fig. S3B</xref>
###xml 2145 2153 2111 2119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s003">Fig. S3A</xref>
Our study provides evidence that altered insulin signaling is associated with mitochondrial function in the beta-cell, as has recently been reported in cardiomyocytes [36]. The mechanism for mitochondrial dysfunction in betaIRKO cells is multifactorial and includes reduced glucose-mediated augmentation in mitochondrial membrane potential and reduced ATP levels that could be due either to decreased synthesis or to increased consumption in order to maintain the membrane potential. Of interest, mitochondrial dysfunction occurs despite increased oxygen consumption. These observations suggest that despite reduced glucokinase activity and potentially reduced glucose delivery to betaIRKO mitochondria they are also uncoupled. One potential mechanism for mitochondrial uncoupling is increased UCP2 expression, which may be driven by increased expression of PGC-1alpha and beta [32], [33]. Moreover, increased UCP2 expression has been implicated in limiting stimulus-secretion coupling in beta-cells in some animal models of diabetes but not in others [31], [37]. However, it is possible that this increased UCP2 expression may not contribute directly to mitochondrial dysfunction in betaIRKO cells and it could be the result of ROS overproduction in response to glucose stimulation since it was found that deletion of insulin receptors in heart increases their propensity to enhance ROS when exposed to fatty acid substrates [36]. Also, DNP experiments suggest that the capacity of the OXPHOS machinery may not be intrinsically impaired in betaIRKO cells; the improvement in oxygen consumption that we see in betaIRKO and the rescued cells might be due to altered mitochondrial mass (Fig. S3B); that might increase total mitochondrial respiration. Together, the mitochondrial defects in betaIRKO cells could be results of combined effects from reduced GK activity, ROS production and altered UCP2 expression. Finally, we also measured mitochondrial membrane potential response to glucose stimulation, and betaIRKO cells that re-expressed the insulin receptors showed a trend towards improved membrane potential response in response to glucose (Fig. S3A), which is also consistent with the increased respiration. Although our experiments have not definitively identified all mechanisms that could account for mitochondrial dysfunction, our study clearly shows that impaired insulin signaling in beta-cells fundamentally alters mitochondrial bioenergetics and function, which may ultimately impair insulin secretion.
###end p 53
###begin p 54
###xml 82 83 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Datta2">[20]</xref>
###xml 668 672 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Shimamura1">[38]</xref>
Consistent with the growth factor-induced phosphorylation and translocation of BADS[20] we observed significant alterations in mitochondria isolated from beta-cells lacking the insulin receptor. The high level of basal phosphorylation of Ser112-BAD and Ser136-BAD in the betaIRKOs likely reflects the effects of signaling via the IGF-1 receptors. It is possible that the relative levels of activation of insulin versus IGF-1 receptors determine the overall phosphorylation state of BAD at the mitochondria, with Ser112 phosphorylation being specifically mediated by Akt-independent pathways, and Ser136 phosphorylation being activated by both Akt and non-Akt pathways [38].
###end p 54
###begin p 55
###xml 118 122 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Bonni1">[22]</xref>
###xml 156 157 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 238 242 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kelekar1">[39]</xref>
###xml 297 304 294 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3SA/3SA</sup>
###xml 431 435 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial2">[16]</xref>
###xml 437 441 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial3">[35]</xref>
###xml 492 493 489 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 640 641 637 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 800 807 794 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g002">Fig. 2B</xref>
###xml 812 820 806 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007983.s002">Fig. S2B</xref>
###xml 895 896 889 890 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1033 1034 1027 1028 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1073 1074 1067 1068 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1256 1260 1250 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial2">[16]</xref>
###xml 1280 1281 1274 1275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1417 1418 1411 1412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1592 1593 1583 1584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 1852 1855 1837 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Otani1">[4]</xref>
###xml 1857 1860 1842 1845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni1">[5]</xref>
###xml 1862 1865 1847 1850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni2">[6]</xref>
###xml 1934 1935 1919 1920 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
###xml 1847 1851 <span type="species:ncbi:10090">mice</span>
Intact IGF-I signaling in betaIRKO cells could mediate the activation of RSK and MSK1 to phosphorylate BAD at Ser-112 [22]. The phosphorylation state of BADS has also been reported to impact its binding with other proteins such as Bcl-XL [39]. Further, the silencing of all serine sites in the BAD3SA/3SA mouse has been reported to reduce GK activity in hepatocytes while disruption of Ser-155 down-regulates GK activity in islets [16], [35]. These studies suggest that phosphorylation of BADS can modulate GK activity and impact apoptosis, likely by disruption of protein interactions in the complex. Our data suggest that the level of BADS phosphorylation correlates with function. This is reflected by the finding that betaIRKO cells exhibit extremely high Ser112 phosphorylation in mitochondria (Fig. 2B and Fig. S2B) and phosphorylation can potentially interrupt the interaction between BADS and other proteins, including GK. Furthermore, re-expression of insulin receptors reversed the increase in Ser112 phosphorylation of BADS and increased the content of total BADS in the complex. Together, these data suggest the potential relevance of interactions between Ser112 phosphorylation and function of the complex. Based on the report by Danial et al [16], restoration of BADS in the complex would augment glucokinase function and mitochondrial metabolism. Additional studies such as mutagenesis of Ser112 of BADS will be necessary to prove a direct role of this phosphorylation event. In betaIRKO mitochondria it is possible that phosphorylation at Ser-112 disrupts the residence of BADS in the mitochondrial complex and alters glucokinase activity and mitochondrial metabolism without affecting Ser-155-BAD (data not shown). These observations are consistent with the altered glucose sensing and altered apoptosis of beta-cells in betaIRKO mice [4], [5], [6]. The ability to reverse basal Ser-112 phoshorylation and restore BADS content to control levels by re-expressing the insulin receptor in betaIRKO cells further underscores the role of insulin signaling in regulating the mitochondrial complex.
###end p 55
###begin p 56
###xml 190 194 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Ueki1">[40]</xref>
###xml 196 200 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Fernandez2">[41]</xref>
###xml 423 427 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Smith1">[34]</xref>
###xml 429 433 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kim3">[42]</xref>
Another signaling pathway that could potentially influence the stoichiometry of the BAD/GK complex is the elevated expression of PTEN secondary to enhanced IGF-I signaling in betaIKRO cells [40], [41]. Increased PIP2 could decrease the binding of PKA in the VCA domain of the WAVE protein, which is known to anchor GK and BAD to the mitochondria to efficiently coordinate spatial and temporal aspects of glucose metabolism [34], [42] and may contribute to the partial normalization of PKA content upon re-expressing the insulin receptor in betaIRKO cells.
###end p 56
###begin p 57
###xml 173 177 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Harrington1">[43]</xref>
###xml 179 185 173 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g007">Fig. 7</xref>
###xml 497 501 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Dickson1">[25]</xref>
In the cytosol, the elevated p70S6K activation in betaIRKO cells could potentially serine-phosphorylate IRS1 and further dampen insulin-stimulation of Akt in betaIRKO cells [43] (Fig. 7), and potentiate IGF-I mediated pathways in the mutant cells. Indeed, activation of Akt/PKB has been reported to inhibit IGF-I activation of MAPK and mTOR pathways via Raf1 kinase, while adenoviral knockdown of Akt/PKB in INS-1 cells leads to enhanced ERK1/ERK2 signaling that is independent of IGF-I signaling [25].
###end p 57
###begin title 58
Schematic showing the impact of insulin/IGF-I signaling on beta-cell mitochondrial metabolism and function.
###end title 58
###begin p 59
Impairment of insulin signaling alters BAD/GK complex and reduces mitochondrial function by inhibiting mitochondrial GK activity. The compensatory increase in IGF-I signaling can impact phosphorylation of mitochondrial BAD to influence glucokinase activity and the mitochondrial threshold to cell death cues; it can also impact mitochondrial p70S6K to phosphorylate BADs. Mitochondrial dysfunction due to impaired insulin signaling can activate mitochondrial JNK1, which can phosphorylate mitochondrial substrate, e.g. BADS, to influence mitochondrial function and sensitivity to stress-induced cell death.
###end p 59
###begin p 60
###xml 211 215 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Aoki1">[44]</xref>
###xml 500 504 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Che1">[45]</xref>
###xml 589 590 580 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 640 646 631 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007983-g007">Fig. 7</xref>
###xml 776 780 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-ONeillBT1">[46]</xref>
###xml 1143 1147 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Patti1">[47]</xref>
###xml 1149 1153 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Abel1">[48]</xref>
We observed high levels of JNK1 activation in mitochondria but not in cytosolic fractions in betaIRKO beta-cells, which is consistent with the report that JNK1 activation is linked to dysfunctional mitochondria [44]. The activation of JNK1 by IGF-I, but not by insulin, in both cytosolic and mitochondrial fractions in control beta-cells, implicates a role for IGF-I in the stress signaling pathway and is consistent with the potentiation of cytokine-mediated JNK following long-term IGF-I treatment [45]. We suggest that JNK1 could potentially contribute to Ser-112 phosphorylation on BADS to affect mitochondrial metabolism and function (Fig. 7). Our observations are consistent with the notion that down-regulation of Akt does not influence basal mitochondrial respiration [46]. It will be useful to dissect further, how insulin and IGF-I signaling pathways differentially modulate MAPK and mTOR target proteins, such as p70S6K and JNK1, to regulate mitochondrial function in beta-cells. Further work is also necessary to explore whether insulin/IGF-I signaling directly modulates PGC-1alpha to affect mitochondrial biogenesis and function [47], [48].
###end p 60
###begin p 61
###xml 215 216 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
In summary, this study provides novel insights into the role of insulin signaling in the regulation of the BAD/GK complex, glycolytic enzyme activity and mitochondrial metabolism in pancreatic beta-cells. Ser112-BADS and its upstream kinases may be potential targets for the maintenance of the BAD/GK complex that is necessary for normal mitochondrial function and the regulation of beta-cell survival.
###end p 61
###begin title 62
Materials and Methods
###end title 62
###begin title 63
Animals and cell lines
###end title 63
###begin p 64
###xml 134 137 128 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni2">[6]</xref>
###xml 464 468 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni4">[49]</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
Experiments were performed using the beta-cell specific insulin receptor knockout mice (betaIRKO) and Lox/Lox littermates as controls [6]. All mice were maintained at the Taconic Facility (NY) or Brandeis University (Waltham, MA). All experiments were performed in compliance with Joslin Diabetes Center and Brandeis University Animal Care and Use Committee regulations. The control and betaIRKO beta-cell lines were derived and maintained as described previously [49].
###end p 64
###begin title 65
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 10 15 <span type="species:ncbi:9606">human</span>
Mouse and human pancreatic islets
###end title 65
###begin p 66
###xml 89 92 89 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni2">[6]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Ichii1">[50]</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
Mouse islets were isolated and purified by collagenase digestion as described previously [6]. Isolated islets were cultured in RPMI media with 10% FBS and 5.5 mM glucose for 48 h before experiments. Islets from controls and patients with type 2 diabetes were obtained from ICR (Islet Cell Resources, CA) and cultured in Miami medium #1 (Mediatech, NJ) [50].
###end p 66
###begin title 67
Mitochondrial isolation
###end title 67
###begin p 68
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Danial2">[16]</xref>
Mitochondria were isolated using conventional differential centrifugation [16]. Briefly, cell lines or islets were homogenized in mitochondrial lysis buffer (220 mM mannitol, 70 mM glucose, 10 mM HEPES, 1 mM EGTA, pH 7.4). Subsequently, the lysate was centrifuged at 700 g to separate nuclear and cytosolic fractions, the cytosolic fraction was further centrifuged at 7000 g at 4degreesC to pellet mitochondria. The isolated mitochondria were subjected either to microcystin capture assay (see below), Western blotting or mitochondrial glucokinase activity assay. For mitochondrial glucokinase activity assays, the isolated mitochondria were further purified through a 30%-70% percoll gradient by centrifugation at 20,000 rpm in a Beckman SW41 rotor for 40 min. The mitochondrial layer in the gradient was removed and washed twice and immediately used for activity assays.
###end p 68
###begin title 69
Microcystin capture assay
###end title 69
###begin p 70
Isolated mitochondria from each respective beta-cell line or from islets were solubilized in the lysis buffer containing 6 mM CHAPS, 150 mM NaCl, 0.01 M sodium phosphate (pH 7.2) and 2 mM EDTA. Based on the specific high affinity of microcystin for protein phosphatase 1 (PP1) (one of the components in the BAD/GK complex), the solubilized mitochondria were incubated with microcystin beads (Upstate, NY) overnight at 4degreesC to pull down the BAD/GK complex. After incubation, the microcystin beads were washed and boiled in protein sample buffer. The protein bound to the microcystin beads were resolved by SDS-PAGE gels and detected by Western blotting to identify the components precipitated on the beads.
###end p 70
###begin title 71
Western blotting
###end title 71
###begin p 72
###xml 317 321 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Kulkarni5">[51]</xref>
To evaluate the role of insulin or IGF-I signaling, cell lines were incubated with 100 nM of either insulin or IGF-I for 15 min at 37degreesC. The 15 min time point was chosen based on pilot experiments to induce signaling effects in mitochondria. Proteins were extracted from cells or islets as previously described [51]. The protein concentration of each sample was determined using a BCA kit (Pierce Biotechnology, Holmdel, NJ). The extracted proteins were resolved by SDS-PAGE, and the protein was transferred to PVDF membrane (Millipore, MA). Western blotting results were normalized to actin and quantitated by densitometry. Antibodies to the following proteins were used: Phospho-BAD, BAD, phospho-p70S6K, p70S6K, phospho-JNK1, JNK1 (Cell Signaling Technology, Boston, MA), glucokinase and protein phosphotase 1 (PP1) (Santa Cruz Biotechnology, Santa Cruz, CA), PKA (Pharmingen, San Jose, CA) and evaluated in cytosol and mitochondrial fractions.
###end p 72
###begin title 73
Glucose-stimulated mitochondrial membrane potential response in beta-cell lines and dispersed islet beta-cells
###end title 73
###begin p 74
###xml 90 94 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Rosen1">[52]</xref>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
beta-cells were dispersed from islets of control or betaIRKO mice as previously described [52]. Dispersed islet cells were cultured in RMPI medium with 10% FBS, antibiotics, 5.5 mM glucose on microscope coverslips and allowed to recover for 48 h. The dispersed islet cells were stained with insulin and glucagon antibodies to confirm purity of beta-cells. Cells were stained with 10 nM TMRE (Molecular probe, Carlsbad, CA) for 45 min prior to glucose stimulation. Fluorescence intensity of cells was initially recorded in the basal condition followed by stimulation with 18 mM glucose. The altered fluorescence of treated cells was recorded under a confocal microscope (Zeiss, Germany) within 10 min. The fluorescence intensity in basal and treated conditions was quantitated by NIH Image J software (n = 60 to 80 cells). The mitochondrial membrane potential change was calculated by averaging fluorescence intensities before and after stimulation.
###end p 74
###begin title 75
Mitochondrial glucokinase activity
###end title 75
###begin p 76
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Niswender1">[53]</xref>
###xml 343 344 331 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 384 390 <span type="species:ncbi:9913">bovine</span>
Mitochondrial glucokinase activity was measured using a glucose-6-phosphate dehydrogenase (G6PDH)-coupled enzyme assay [53]. The total NADPH generated reflects glucokinase activity in mitochondria. Briefly, approximately3 mg of isolated mitochondria was resuspended in reaction buffer containing 50 mM triethanolamine hydrochloride, 20 mM MgCl2, 100 mM KCl, 1 mM dithiothreitol, 0.1% bovine serum albumin, 10 mM ATP, 1 mM NADP and 4 microg/ml glucose-6-phosphate dehydrogenase (Sigma, St. Louis, MO). Then, 90 mM glucose was added to initiate the reaction and monitored by absorbance at 340 nm for 20 min at RT. In order to decrease NADPH background generated from mitochondrial respiration, all reactions were performed in the presence of mitochondrial respiration inhibitors (4 microM Rotenone, 100 nM Antimycin A and 2 microg/ml Oligomycin).
###end p 76
###begin title 77
Electron microscopy and determination of mitochondrial number, size and volume density
###end title 77
###begin p 78
###xml 670 674 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Bugger1">[54]</xref>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
Islets were fixed with 2.5% glutaraldehyde at RT for 2 h. Ultra-thin sections (approximately60 nm) were cut and stained with uranyl acetate and lead citrate before being examined under JOEL Transmission Electron Microscope (Tokyo, Japan). At least five islets were chosen randomly from control or betaIRKO mouse islets and approximately4 randomly selected beta-cells from each islet were photographed. At least 15 islet beta-cells were examined from control or betaIRKO islets for number and morphology of the mitochondria. Mitochondrial volume density and number were analyzed by stereology in a blinded fashion using the point counting method, as described previously [54]. Five representative images were analyzed per genotype, and four grids per image were analyzed. Average size of the mitochondria was calculated by dividing mitochondrial volume density by mitochondrial number.
###end p 78
###begin title 79
Re-expression of insulin receptor in betaIRKO cells
###end title 79
###begin p 80
###xml 502 502 502 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 738 738 734 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 477 483 <span type="species:ncbi:9913">bovine</span>
Retroviral-packaging ∅ (Phoenix cells carrying the retroviral vector was kindly provided by C. R. Kahn, MD (Joslin Diabetes Center, Boston, MA). The vector encoding human insulin receptor B was obtained from I. Leibiger, Ph.D (Karolinska Institute, Stockholm, Sweden). Briefly, empty vector or vector expressing the insulin receptor was transfected using lipofectamine (Invitrogen, Carlsbad, CA) in O cells. The day after transfection, DMEM medium, supplemented with 10% fetal bovine serum (FBS) and 50microg/ml gentamicin (Gibco, Invitrogen, Carlsbad, CA) was replaced. Supernatant was collected 48 h post-transfection and subjected to ultracentrifugation using an SW-28 rotor at 20,000 rpm. The transparent pellet was resuspended in 500microl phosphate buffered saline (PBS, pH 7.4), aliquoted and stored at -80degreesC until further use. betaIRKO cells were transfected with retrovirus particles. Twenty four h after transfection, 400 microg/ml hygromycin (Gibco, Invitrogen, Carlsbad, CA) was added to select the cells in which the expression vector was successfully integrated.
###end p 80
###begin title 81
Measurement of Mitochondrial Respiration
###end title 81
###begin p 82
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007983-Amiott1">[55]</xref>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 750 757 744 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
Oxygen consumption rates (OCR) were measured in whole cells by using a fiber-optic oxygen sensing probe as previously described [55] or the Seahorse XF24. Briefly, cells were suspended at a concentration of 2x106 cells/ml by a magnetic stirrer at 37degreesC in a volume of 1 ml of buffer TD (137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 25 mM Tris-Cl, pH 7.4) and transferred to the oxygen chamber. Endogenous (basal) respiration was measured for 1 min. Glucose (final concentration 25 mM) or the uncoupler 2,4-dinitrophenol (DNP) was injected into the chamber (83 mM final), and stimulated rates of oxygen consumption were determined. The Seahorse machine (Seahorse Bioscience, Billerica, MA) was used to measure oxygen consumption rate in adherent cells in situ without trypsinization.
###end p 82
###begin title 83
ATP assay
###end title 83
###begin p 84
Cells were seeded in 12-well plates and incubated for 36-48 h before incubation for an additional 16 h with 2 mM glucose in DMEM with 0.1% BSA, followed by 2 mM glucose in KRB buffer for one h. The cells were then either incubated in KRB buffer containing 2 mM glucose (basal concentration) or KRB buffer containing 25 mM glucose (stimulatory concentration) for 30 min. ATP was then extracted with 0.5% TCA solution for 15 min at 4degreesC. An aliquot of the TCA extracted samples were diluted 20X with 0.1 M Tris-HCl, pH 7.75 buffer just before ATP measurement with the ENLITEN(R) ATP Assay System Bioluminescence Detection Kit (Promega, Madison, WI) according to the manufacturer's recommendation. Total protein concentration was measured using the BCA protein Assay (Pierce, Rockford, IL), and ATP generated was normalized to total protein.
###end p 84
###begin title 85
Statistics
###end title 85
###begin p 86
Data were analyzed by Student's 't' test or analyses of variance (ANOVA) with post-hoc comparisons as appropriate. Unless otherwise indicated all experiments were performed on at least three independent occasions.
###end p 86
###begin title 87
Supporting Information
###end title 87
###begin p 88
###xml 87 108 84 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
Mitochondrial purity assay. Mitochondria were isolated from beta-cells as described in Materials and Methods. To examine the purity of either the mitochondrial or cytosolic fraction, a mitochondrial marker COX4 or a cytosolic marker actin were immunoblotted for each fraction.
###end p 88
###begin p 89
(0.20 MB PPT)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 208 209 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 221 222 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 236 237 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 380 381 374 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 464 465 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
Distribution of BAD and phospho-BADS in beta cells. Control or betaIRKO cells were treated with 100 nM insulin for 15 min and fractionated, cytosol, mitochondria and total lysates were examined. A, Ser136-BADS, Ser112-BADS and total BADS were immunoblotted. Tubulin and COX4 were used as loading control for cytosol and mitochondria respectively. B, Magnified image for Ser112-BADS in cytosol, mitochondria and total cell lysate. L and S denote the isoforms of BADS.
###end p 91
###begin p 92
(0.15 MB PPT)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
Altered mitochondrial membrane potential and mass. A. Control, betaIRKO or betaIRKO+hIRB (betaIRKO cells re-expressing insulin receptors) cells were treated with 16.7 mM glucose and stained with TMRE. The mitochondrial membrane potential change was calculated by averaging fluorescence intensities before and after stimulation. *p<0.05, control vs. betaIRKO; p = 0.068, betaIRKO vs. betaIRKO+hIRB; n = 4. B. Control, betaIRKO or betaIRKO cells re-expressing insulin receptors (betaIRKO+hIRB) cells were stained by Mitotracker dye and analyzed by flow cytometry; *p<0.05, control vs. betaIRKO, and betaIRKO vs. betaIRKO+hIRB; n = 3.
###end p 94
###begin p 95
(0.07 MB PPT)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 421 428 421 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Western immunoblotting of the five components in BAD/GK complex in islets from patients with type 2 diabetes. Islets from three controls and three patients with type 2 diabetes were fractionated and mitochondrial fractions were assessed using a mycrocystin pull-down assay. The pull-down was used to detect the five components that constitute the BAD/GK complex, using antibodies indicated in the figure and described in Methods.
###end p 97
###begin p 98
(0.43 MB PPT)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 93 97 <span type="species:ncbi:10090">mice</span>
We thank Nika Danial PhD for discussions, Jiang Hu for excellent assistance with maintaining mice and immunostaining, and Lindsay Huse and Liz Morgan for excellent assistance with preparation of the manuscript.
###end p 100
###begin title 101
References
###end title 101
###begin article-title 102
Signalling through IGF-I and insulin receptors: where is the specificity?
###end article-title 102
###begin article-title 103
Cellular survival: a play in three Akts.
###end article-title 103
###begin article-title 104
Growth factor control of pancreatic islet regeneration and function.
###end article-title 104
###begin article-title 105
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice.
###end article-title 105
###begin article-title 106
beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass.
###end article-title 106
###begin article-title 107
Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.
###end article-title 107
###begin article-title 108
Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2.
###end article-title 108
###begin article-title 109
Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.
###end article-title 109
###begin article-title 110
###xml 103 111 <span type="species:ncbi:9606">patients</span>
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.
###end article-title 110
###begin article-title 111
Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm.
###end article-title 111
###begin article-title 112
The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy.
###end article-title 112
###begin article-title 113
Minireview: implication of mitochondria in insulin secretion and action.
###end article-title 113
###begin article-title 114
Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying ceramide-mediated metabolic dysfunction of the beta cell.
###end article-title 114
###begin article-title 115
Cell death: critical control points.
###end article-title 115
###begin article-title 116
IGF-I mediated survival pathways in normal and malignant cells.
###end article-title 116
###begin article-title 117
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis.
###end article-title 117
###begin article-title 118
Mitochondrial dysfunction: glucokinase downregulation lowers interaction of glucokinase with mitochondria, resulting in apoptosis of pancreatic beta-cells.
###end article-title 118
###begin article-title 119
Exposure to chronic high glucose induces beta-cell apoptosis through decreased interaction of glucokinase with mitochondria: downregulation of glucokinase in pancreatic beta-cells.
###end article-title 119
###begin article-title 120
New insights into the roles of insulin/IGF-I in the development and maintenance of beta-cell mass.
###end article-title 120
###begin article-title 121
Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis.
###end article-title 121
###begin article-title 122
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.
###end article-title 122
###begin article-title 123
Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.
###end article-title 123
###begin article-title 124
14-3-3 inhibits Bad-induced cell death through interaction with serine-136.
###end article-title 124
###begin article-title 125
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD.
###end article-title 125
###begin article-title 126
Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1).
###end article-title 126
###begin article-title 127
Sab (SH3BP5), a novel mitochondria-localized JNK-interacting protein.
###end article-title 127
###begin article-title 128
The essential role of the death domain kinase receptor-interacting protein in insulin growth factor-I-induced c-Jun N-terminal kinase activation.
###end article-title 128
###begin article-title 129
Glucose-dependent increase in mitochondrial membrane potential, but not cytoplasmic calcium, correlates with insulin secretion in single islet cells.
###end article-title 129
###begin article-title 130
beta-Cell mitochondria exhibit membrane potential heterogeneity that can be altered by stimulatory or toxic fuel levels.
###end article-title 130
###begin article-title 131
Changes in mitochondrial membrane potential and mitochondrial mass occur independent of the activation of caspase-8 and caspase-3 during CD95-mediated apoptosis in peripheral blood T cells.
###end article-title 131
###begin article-title 132
Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.
###end article-title 132
###begin article-title 133
Transcriptional co-activator peroxisome proliferator-activated receptor (PPAR)gamma co-activator-1beta is involved in the regulation of glucose-stimulated insulin secretion in INS-1E cells.
###end article-title 133
###begin article-title 134
###xml 117 122 <span type="species:ncbi:9606">human</span>
Role of peroxisome proliferator-activated receptor-gamma coactivator-1alpha in the transcriptional regulation of the human uncoupling protein 2 gene in INS-1E cells.
###end article-title 134
###begin article-title 135
The where's and when's of kinase anchoring.
###end article-title 135
###begin article-title 136
Dual role of proapoptotic BAD in insulin secretion and beta cell survival.
###end article-title 136
###begin article-title 137
Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.
###end article-title 137
###begin article-title 138
Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic beta-cell function.
###end article-title 138
###begin article-title 139
Rsk1 mediates a MEK-MAP kinase cell survival signal.
###end article-title 139
###begin article-title 140
Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL.
###end article-title 140
###begin article-title 141
Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes.
###end article-title 141
###begin article-title 142
Modulation by insulin-like growth factor I of the phosphatase PTEN in astrocytes.
###end article-title 142
###begin article-title 143
Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein.
###end article-title 143
###begin article-title 144
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins.
###end article-title 144
###begin article-title 145
Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes.
###end article-title 145
###begin article-title 146
Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression.
###end article-title 146
###begin article-title 147
A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy.
###end article-title 147
###begin article-title 148
###xml 58 64 <span type="species:ncbi:9606">humans</span>
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.
###end article-title 148
###begin article-title 149
Myocardial insulin resistance and cardiac complications of diabetes.
###end article-title 149
###begin article-title 150
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines.
###end article-title 150
###begin article-title 151
###xml 41 46 <span type="species:ncbi:9606">human</span>
Rescue purification maximizes the use of human islet preparations for transplantation.
###end article-title 151
###begin article-title 152
###xml 146 150 <span type="species:ncbi:10090">mice</span>
Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice.
###end article-title 152
###begin article-title 153
Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.
###end article-title 153
###begin article-title 154
Cell-specific expression and regulation of a glucokinase gene locus transgene.
###end article-title 154
###begin article-title 155
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3.
###end article-title 155
###begin article-title 156
###xml 65 72 <span type="species:ncbi:9606">patient</span>
Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations.
###end article-title 156
###begin p 157
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 157
###begin p 158
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by grants from the NIH DK RO1 68721 (R.N.K.), NIH DK RO1 67536 (R.N.K.), NIH HL RO1 73167 (E.D.A.), and the Joslin DERC P30DK36836 (Specialized Assay and Advanced Microscopy Cores). HB was supported by a grant from the German Research Foundation DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 158

